Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncoimmunology|August 7, 2023
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancerTatiana V Kudling, James H A Clubb, Santeri Pakola, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2024
Safety, Efficacy, and Biological Data of T-Cell-Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I TrialSanteri A Pakola, Katriina J Peltola, James H A Clubb, et al.Oncoimmunology|July 18, 2022
Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regressionTatiana V Kudling, James H A Clubb, Dafne C A Quixabeira, et al.Journal of Experimental & Clinical Cancer Research : CR|November 7, 2024
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumorsElise Jirovec, Dafne C A Quixabeira, James H A Clubb, et al.Frontiers in Immunology|February 23, 2023
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive settingJames H A Clubb, Tatiana V Kudling, Mykhailo Girych, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2026
Fully intravenous split-dose administration of the oncolytic adenovirus TILT-123 in advanced solid tumorsElise Jirovec, Katriina J Jalkanen, Dafne C A Quixabeira, et al.Cell Reports. Medicine|March 19, 2025
Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanomaTine J Monberg, Santeri A Pakola, Benedetta Albieri, et al.Pageof 2